NCT00644189 2023-03-15Oral Clofarabine for Relapsed/Refractory Non-Hodgkin LymphomaMassachusetts General HospitalPhase 1/2 Completed50 enrolled 15 charts
NCT00691652 2019-11-27Clofarabine and Rituximab in Treating Patients With Relapsed Non-Hodgkin LymphomaOHSU Knight Cancer InstitutePhase 1/2 Terminated2 enrolled 4 charts
NCT00626626 2018-04-25Clofarabine and Non-Myeloablative Allogeneic Hematopoietic TransplantationMilton S. Hershey Medical CenterPhase 1/2 Terminated8 enrolled 9 charts
NCT00617929 2017-12-28Antithymocyte Globulin, Clofarabine, and Rituximab in Treating Patients After an Unsuccessful Stem Cell TransplantMasonic Cancer Center, University of MinnesotaPhase 2 Terminated12 enrolled 12 charts